These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 16185473

  • 1. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 4. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Dec; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 6. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 7. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 Jul; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
    Liu YR, Zhang LP, Chang Y, Cheng YF, Fu JY, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):302-5. PubMed ID: 16875577
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 May; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 11. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B.
    Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
    [Abstract] [Full Text] [Related]

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A.
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [Abstract] [Full Text] [Related]

  • 13. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 14. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O, Zelezníková T, Mlcáková A, Kusenda J, Stevulová L.
    Neoplasma; 2005 Jun; 52(6):502-9. PubMed ID: 16284697
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
    Liu YR, Chang Y, Fu JY, Cheng YF, Zhang LP, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
    [Abstract] [Full Text] [Related]

  • 16. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M, Sun XF, Xu ZM, Zhang XY, Li FR, Wang XG, Chen XL, Lin HQ, Wen HG, Sun X, Song TW.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [Abstract] [Full Text] [Related]

  • 17. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
    Patkar N, Alex AA, B B, Ahmed R, Abraham A, George B, Vishwabandya A, Srivastava A, Mathews V.
    Cytometry B Clin Cytom; 2012 Jul; 82(4):252-8. PubMed ID: 22467604
    [Abstract] [Full Text] [Related]

  • 18. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
    Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Panda D, Pradhan SN, Girase K, Narula G, Dhamane C, Malik NR, Banavali S, Patkar NV, Gujral S, Subramanian PG, Tembhare PR.
    Cytometry B Clin Cytom; 2021 Jul; 100(4):434-445. PubMed ID: 32896101
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F, Lo Verso R, Giambanco C, Cardinale G, Tomaselli C, Pagnucco G.
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [Abstract] [Full Text] [Related]

  • 20. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
    Cai JY, Tang YJ, Jiang LM, Pan C, Chen J, Tang JY.
    Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.